Induced Pluripotent Stem Cells: Global Markets

Report Highlights:

The global induced pluripotent stem cells (iPSC) market should reach $3.8 billion by 2024 from $2.4 billion in 2019 at a compound annual growth rate (CAGR) of 9.2% for the forecast period of 2019 to 2024.

The U.S. region of the global iPSC market is expected to grow from $1.2 billion in 2019 to $1.8 billion in 2024 at a CAGR of 8.8% for the forecast period of 2019 to 2024.

The Asia-Pacific region of the global iPSC market is expected to grow from $585 million in 2019 to $977 million in 2025 at a CAGR of 10.8% for the forecast period of 2019 to 2024.

Report Scope:

This study is focused on the market side of iPSCs rather than its technical side. Different market segments for this emerging market are covered. For example, application-based market segments include academic research, drug development and toxicity testing, and regenerative medicine; product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation and cell analysis; iPSC-derived cell-type-based market segments include cardiomyocytes, hepatocytes, neurons, endothelia cells and other cell types; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of the World. Research and market trends are also analyzed by studying the funding, patent publications and research publications in the field.

Report Includes:

• 59 tables

• An overview of the global market for induced pluripotent stem cells

• Analyses of global market trends with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024

• Information on induced pluripotent stem cell research products, including various assays and kits, culture media and medium components, such as serum, growth factors and inhibitors, antibodies, enzymes

• Complete understanding of the key technologies adopted for induced pluripotent stem cell research

• Discussion of important manufacturers, technologies, and factors influencing market demand, such as the driving forces and limiting factors of induced pluripotent stem cell market growth

• Profiles of major players in the industry, including Applied StemCell Inc., BlueRock Therapeutics, Corning Life Sciences, EMD Millipore, Lonza Group Ltd., Promega Corp. and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1: Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Intended Audience
• Scope of Report
• Methodology
• Information Sources
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2: Summary and Highlights

• Key Drivers for Market Growth

Chapter 3: Overview

• Introduction
• History and Current State
• Evolution of Induced Pluripotent Stem Cell Research
• Advantages and Disadvantages of Induced Pluripotent Stem Cells
  • Advantages
  • Disadvantages
• Technology Overview
  • Induced Pluripotent Stem Cell Generation
  • Induced Pluripotent Stem Cell Differentiation
  • Current Challenges to iPSC Applications

Chapter 4: Induced Pluripotent Stem Cell Applications

• Academic Research
• Pharmaco-Toxicological Screening
• Drug Discovery and Development
• Disease Modeling
• Tissue Engineering
• Cell Therapy

Chapter 5: Induced Pluripotent Stem Cell Market Segmentation and Forecast

• Market Overview
• Application-Based Market Overview
• U.S. Induced Pluripotent Stem Cell Product Market
• Induced Pluripotent Stem Cell-Derived Tissue Cell Market
• Induced Pluripotent Stem Cell and Derivative Cell Market
• Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
• Market for Induced Pluripotent Stem Cell-Derived Cells by Application
• Market for Induced Pluripotent Stem Cell by Product Function
  • Global Market
  • Regional Markets
• Research Market Compared with the Clinical Market
• Application-Based Markets for Induced Pluripotent Stem Cell-Derived Cells
  • Market for Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells
  • Market for Human Hepatocytes Derived from Induced Pluripotent Stem Cells
  • Market for Human Endothelia Cells Derived from Induced Pluripotent Stem Cells
  • Regional Markets
  • Market for Human Neural Cells Derived from Induced Pluripotent Stem Cells
  • Regional Markets
• Induced Pluripotent Stem Cells and Their Derived Cells Market by Species
  • Global Market
  • Regional Markets
• Induced Pluripotent Stem Cell Culture Markets

Chapter 6: Induced Pluripotent Stem Cell Research Application Market

• Induced Pluripotent Stem Cell Research Product Types
• Major Players
  • Major Commercial Entities
  • Major Non-Commercial Organizations
• Market Shares and Projections

Chapter 7: Drug Discovery and Development Market

• Product Types
• Major Players
• Market Shares and Projections

Chapter 8: Induced Pluripotent Stem Cell Contract Service Market

• Induced Pluripotent Stem Cell Contract Service Types
• Major Players
• Market Shares and Projections

Chapter 9: Induced Pluripotent Stem Cell Clinical Application Market

• Product Types
• Regulations
• Market Projection

Chapter 10: Research Market Trend Analysis

• Grant Analysis
• Patent Analysis
• Scientific Publication Analysis
• Driving Forces

Chapter 11: Clinical Application Market Trend Analysis

• Clinical Trials
  • Age-Related Macular Degeneration
  • Ischemic Heart Disease
  • Parkinson's Disease
  • Graft-versus-Host Disease (GvHD)
  • Spine Cord Injuries
  • Cornea Repair
  • Cancers
• Driving Forces
• Limiting Factors
  • Technologies
  • Regulations
  • Market Acceptance
  • Clinical Efficiency

Chapter 12: Company Profiles

• ABM (APPLIED BIOLOGICAL MATERIALS INC.)
• ADDGENE
• ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC.
• ALSTEM LLC
• APPLIED STEMCELL INC.
• ATCC
• AXOL BIOSCIENCE‎
• BIO-TECHNE
• BLUEROCK THERAPEUTICS
• BRISTOL-MYERS SQUIBB (IPIERIAN)
• CELL SIGNALING TECHNOLOGY
• CELLULAR DYNAMICS INTERNATIONAL, A FUJIFILM COMPANY
• CORNING LIFE SCIENCES
• CREATIVE BIOARRAY‎
• EMD MILLIPORE
• FATE THERAPEUTICS
• GENECOPOEIA
• GENTARGET INC.
• ID PHARMA CO., LTD.
• INVIVOGEN
• LONZA GROUP LTD.
• MEGAKARYON CORP.
• MTI-GLOBALSTEM, A PART OF THERMO FISHER SCIENTIFIC
• NCARDIA
• NEWCELLS BIOTECH
• OPSIS THERAPEUTICS
• ORIG3N INC.
• PEPROTECH
• PLASTICELL LTD.
• PRIMORIGEN BIOSCIENCES
• PROMEGA CORP.
• PROMOCELL GMBH
• QIAGEN N.V.
• REPROCELL INC.
• ROSLIN CELL SCIENCES
• SCIENCELL RESEARCH LABORATORIES
• SIGMA-ALDRICH, A PART OF MILLIPORESIGMA
• STEMCELL TECHNOLOGIES‎
• STEMGENT INC., A REPROCELL GROUP CO.
• SYSTEM BIOSCIENCES INC.
• TAKARA BIO USA INC. (CLONTECH LABORATORIES)
• THERMO FISHER SCIENTIFIC
• VIACYTE INC.
• WAISMAN BIOMANUFACTURING

Chapter 13: Conclusions

List of Tables

• Summary Table: Global Market for Induced Pluripotent Stem Cells, by Region, Through 2024
  • Table 1: U.S. Market for Induced Pluripotent Stem Cell Products, by U.S. State, Through 2024
  • Table 2: Global Market for the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2024
  • Table 3: Global Market for the Generation of Induced Pluripotent Stem Cells, by Method, Through 2024
  • Table 4: Global Market for Induced Pluripotent Stem Cell Products, by Application, Through 2024
  • Table 5: U.S. Market for Induced Pluripotent Stem Cell Products, by Application, Through 2024
  • Table 6: Global Market for Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, Through 2024
  • Table 7: Global Market for Induced Pluripotent Stem Cell-Derived Cells, by Species, Through 2024
  • Table 8: Major Commercial Suppliers of Induced Pluripotent Stem Cell Products, by Country, October 31, 2019
  • Table 9: Major U.S. Commercial Manufacturers of Induced Pluripotent Stem Cells, by Country, October 31, 2019
  • Table 10: Global Market for Induced Pluripotent Stem Cell-Derived Cells, by Application, Through 2024
  • Table 11: Global Market for Induced Pluripotent Stem Cell-Related Products, by Product Function, Through 2024
  • Table 12: U.S. Market for Induced Pluripotent Stem Cell-Related Products, by Product Function, Through 2024
  • Table 13: Global Market for Induced Pluripotent Stem Cells in Research and Clinical Uses, Through 2024
  • Table 14: Global Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, Through 2024
  • Table 15: U.S. Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, Through 2024
  • Table 16: European Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, Through 2024
  • Table 17: Asia-Pacific Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, Through 2024
  • Table 18: Global Market for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, Through 2024
  • Table 19: U.S. Market for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, Through 2024
  • Table 20: European Market for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, Through 2024
  • Table 21: Asia-Pacific Market for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, Through 2024
  • Table 22: Global Market for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, Through 2024
  • Table 23: U.S. Market for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, Through 2024
  • Table 24: European Market for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, Through 2024
  • Table 25: Asia-Pacific Market for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, Through 2024
  • Table 26: Global Market for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, Through 2024
  • Table 27: U.S. Market for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, Through 2024
  • Table 28: European Market for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, Through 2024
  • Table 29: Asia-Pacific Market for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, Through 2024
  • Table 30: Global Market for Induced Pluripotent Stem Cells and Derivative Cells, by Species, Through 2024
  • Table 31: U.S. Market for Induced Pluripotent Stem Cells and Derivative Cells, by Species, Through 2024
  • Table 32: European Market for Induced Pluripotent Stem Cells and Derivative Cells, by Species, Through 2024
  • Table 33: Asia-Pacific Market for Induced Pluripotent Stem Cells and Derivative Cells, by Species, Through 2024
  • Table 34: Global Market for Cell Culture Products for Induced Pluripotent Stem Cells and Derived Cells, by Region, Through 2024
  • Table 35: Global Market for Induced Pluripotent Stem Cell-Related Products, by Function, Through 2024
  • Table 36: U.S. Market for Induced Pluripotent Stem Cell-Related Products, by Function, Through 2024
  • Table 37: Global Market for Induced Pluripotent Stem Cell-Derived Cell Products for Research, by Cell Type, Through 2024
  • Table 38: Global Market for Induced Pluripotent Stem Cell Products for Academic Research, by Region, Through 2024
  • Table 39: Major University and Institute Induced Pluripotent Stem Cell Core Facilities, by Location
  • Table 40: Global Market for Induced Pluripotent Stem Cell Products for Drug Development and Toxicity Testing, by Cell Type, Through 2024
  • Table 41: Global Market for Induced Pluripotent Stem Cell Products for Drug Development and Toxicity Testing, by Region, Through 2024
  • Table 42: Major Companies Providing Induced Pluripotent Stem Cell Contract Services, 2019
  • Table 43: Global Market for Induced Pluripotent Stem Cell Contract Services, by Region, Through 2024
  • Table 44: Global Market for Induced Pluripotent Stem Cell-Derived Products for Regenerative Medicine, by Cell Type, Through 2024
  • Table 45: Global Market for Induced Pluripotent Stem Cell Products for Clinical Applications (Including Patient-Specific iPSC Banking), by Region, Through 2024
  • Table 46: Major Governmental Induced Pluripotent Stem Cell Research Funding, by Region, 2006-October 2019
  • Table 47: National Institutes of Health Induced Pluripotent Stem Cells Research Funding, 2006-October 2019
  • Table 48: California Institute of Regenerative Medicine Induced Pluripotent Stem Cell Funding, October 2019
  • Table 49: U.S. Patents on Induced Pluripotent Stem Cells, 2017-October 2019
  • Table 50: Shares of Global Patents or Patent Applications on Induced Pluripotent Stem Cells, by Region, 2011-October 2019
  • Table 51: Distribution of Patents and Patent Applications on Induced Pluripotent Stem Cells, by Patent Office or Country, 2011-October 2019
  • Table 52: Main Inventors Listed on Global Patents or Patent Applications on Induced Pluripotent Stem Cells, 2011-October 2019
  • Table 53: Main Applicants Listed on Global Patents or Patent Applications on Induced Pluripotent Stem Cells, 2011-October 2019
  • Table 54: Global Patents and Patent Applications on Induced Pluripotent Stem Cells, by Year, 2008-October 2019
  • Table 55: U.S. Patents on Induced Pluripotent Stem Cells, 2009-October 2019
  • Table 56: Global Patents and Patent Applications Filed with the USPTO on Induced Pluripotent Stem Cells, by Assignee's Country, October 2019
  • Table 57: U.S. Patents on Induced Pluripotent Stem Cells, by U.S. State, October 2019
  • Table 58: Scientific Publications of Induced Pluripotent Stem Cell Research, 2006-October 2019

List of Figures

• Summary Figure: Global Market for Induced Pluripotent Stem Cells, by Region, 2018-2024
  • Figure 1: Global Market Shares of Induced Pluripotent Stem Cell Products, by Region, 2024
  • Figure 2: U.S. Market Shares of Induced Pluripotent Stem Cell Products, by U.S. State, 2024
  • Figure 3: Global Market Shares of the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, 2024
  • Figure 4: Global Market Shares of the Generation of Induced Pluripotent Stem Cell, by Method, 2024
  • Figure 5: Global Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2024
  • Figure 6: U.S. Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2024
  • Figure 7: Global Market Shares of Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, 2024
  • Figure 8: Shares of Major Commercial Suppliers of Induced Pluripotent Stem Cell Products, by Country, 2019
  • Figure 9: Shares of Major U.S. Commercial Suppliers of Induced Pluripotent Stem Cell Products, by U.S. State, 2019
  • Figure 10: Shares of Major U.S. Commercial Manufacturers of Induced Pluripotent Stem Cell Products, by Country, 2019
  • Figure 11: Shares of Major U.S. Commercial Induced Pluripotent Stem Cell Product Manufacturers, by State, 2019
  • Figure 12: Global Market Shares of Induced Pluripotent Stem Cell-Derived Cells, by Application, 2024
  • Figure 13: Global Market Shares of Induced Pluripotent Stem Cell-Related Products, by Product Function, 2024
  • Figure 14: U.S. Market Shares of Induced Pluripotent Stem Cell-Related Products, by Product Function, 2024
  • Figure 15: Global Market Shares of Induced Pluripotent Stem Cells in Research and Clinical Uses, 2024
  • Figure 16: Global Market Shares of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, 2024
  • Figure 17: U.S. Market Shares of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, 2024
  • Figure 18: European Market Shares of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, 2024
  • Figure 19: Asia-Pacific Market Shares of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, 2024
  • Figure 20: Global Market Shares of Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, 2024
  • Figure 21: U.S. Market Shares of Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, 2024
  • Figure 22: European Market Shares of Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, 2024
  • Figure 23: Asia-Pacific Market Shares of Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, 2024
  • Figure 24: Global Market Shares of Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, 2024
  • Figure 25: U.S. Market Shares of Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, 2024
  • Figure 26: European Market Shares of Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, 2024
  • Figure 27: Asia-Pacific Market Shares of Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, 2024
  • Figure 28: Global Market Shares of Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, 2024
  • Figure 29: U.S. Market Shares of Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, 2024
  • Figure 30: European Market Shares of Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, 2024
  • Figure 31: Asia-Pacific Market Shares of Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, 2024
  • Figure 32: Global Market Shares of Induced Pluripotent Stem Cells and Derivative Cells, by Species, 2024
  • Figure 33: Global Market Shares of Cell Culture Products for Induced Pluripotent Stem Cells and Derived Cells, by Region, 2024
  • Figure 34: Global Market Shares of Induced Pluripotent Stem Cell-Related Products, by Function, 2024
  • Figure 35: U.S. Market Shares for Induced Pluripotent Stem Cell-Related Products, by Function, 2024
  • Figure 36: Global Market Shares of Induced Pluripotent Stem Cell-Derived Cell Products for Research, by Cell Type, 2024
  • Figure 37: Global Market Shares of Induced Pluripotent Stem Cell Products for Academic Research, by Region, 2024
  • Figure 38: Global Market Shares of Induced Pluripotent Stem Cell Products for Drug Development and Toxicity Testing, by Cell Type, 2024
  • Figure 39: Global Market Shares of Induced Pluripotent Stem Cell Products for Drug Development and Toxicity Testing, by Region, 2024
  • Figure 40: Global Market Shares of Induced Pluripotent Stem Cell Contract Services, by Region, 2024
  • Figure 41: Global Market Shares of Induced Pluripotent Stem Cell-Derived Products for Regenerative Medicine, by Cell Type, 2024
  • Figure 42: Global Market Shares of Induced Pluripotent Stem Cells Products for Clinical Applications (Including Patient-Specific iPSC Banking), by Region, 2024
  • Figure 43: Shares of Major Governmental Induced Pluripotent Stem Cell Research Funding, by Region, 2006-October 2019
  • Figure 44: Shares of Funding Amount for National Institutes of Health Induced Pluripotent Stem Cell Research, 2006-October 2019
  • Figure 45: Number of Global Patents and Patent Applications on Induced Pluripotent Stem Cells, 2008-October 2019
  • Figure 46: Shares of U.S. Patents on Induced Pluripotent Stem Cells, 2009-October 2019
  • Figure 47: Scientific Publications of Induced Pluripotent Stem Cell Research, 2006-October 2019